No abstract

The preparation and distribution of medication in prisons or jails are critical for individuals to access their treatment. This process is resource-intensive for healthcare professionals and may violate principles of confidentiality, autonomy, respect, and dignity if non-qualified staff are involved. However, there are no published best practices on the topic. This report aims to bridge this gap by presenting the results of a mapping exercise on different models of medication preparation and delivery. Authors call upon healthcare professionals to enrich this live document to inform health services research further and improve access to prescribed medications for people experiencing incarceration.

The preparation and dispensing of medication in prisons or jails are critical for individuals to access their treatment. This process is resource-intensive for healthcare professionals and may violate principles of confidentiality, autonomy, respect, and dignity if non-qualified staff are involved. However, there are no published best practices on the topic. This report aims to bridge this gap by presenting the results of a mapping exercise on different models of medication preparation and dispensing. Authors call upon healthcare professionals to enrich this live document to inform health services research further and improve access to prescribed medications for people experiencing incarceration.

Background Pharmacists are responsible for system quality and patient safety and make a valuable contribution to the medication process in chemotherapy. PurposeAn assessment and inventory of non-conformity (NC) took place in the chemotherapy preparation area of the hospital’s anti-cancer unit (PCAU). The importance of the pharmacist in the medication process in chemotherapy was assessed. Materials and MethodsTwo activities were studied for 18 weeks: the analysis of the physician’s prescriptions (using Chimio® software) and the preparation of the treatment by the pharmacy assistant. An assessment grid was made for each of these activities. NC was flagged in the data whenever it was detected by the pharmacist (or the intern) in order for the anomalies to be corrected. ResultsRegarding NC in prescriptions: 149 NC events were quantified in 3936 lines (3.79%): 54.4% had an impact on the patient’s health; mistakes in the progression of the course of treatment (14.81%), in indication and/or diagnosis (13.58%), in the dose of anti-cancer chemotherapy (12.35%) or in the date of administration (11.11%). 45.6% had a financial impact (alternation and rounded dosages, 88.24%) Regarding NC in preparation, 88 NC events were quantified in 3374 preparations (2.61%) – omissions of light-protective containers (23.86%), and of double checking (required in the chemotherapy medication process) (14.77%), or omission faults (13.64%). All anomalies were noted and corrected. Conclusions Although there is a validated quality assurance system, the intervention of a pharmacist (or intern) is important at key stages of the sequence to allow the detection of NC that is not highlighted by prescribers or preparers. No conflict of interest.

No abstract